Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant

Yaqing Cao; Jingjing Shang; Yingying Zhai; Qingyuan Wang; Lingzhi Yan; Xiaolan Shi; Jing Wang; Ying Yao; Huifen Zhou; Aining Sun; Miao Miao; Chengcheng Fu; Song Jin

doi:10.1080/10428194.2024.2329322

Successful treatment with bortezomib, thalidomide and dexamethasone in plasma cell myeloma post-bone marrow transplant

Leuk Lymphoma. 2024 Apr 1:1-4. doi: 10.1080/10428194.2024.2329322. Online ahead of print.

Authors

Yaqing Cao^{1

2

3}, Jingjing Shang^{1

2

3}, Yingying Zhai^{1

2

3}, Qingyuan Wang^{1

2

3}, Lingzhi Yan^{1

2

3}, Xiaolan Shi^{1

2

3}, Jing Wang^{1

2

3}, Ying Yao^{1

2

3}, Huifen Zhou^{1

2

3}, Aining Sun^{1

2

3}, Miao Miao^{1

2

3}, Chengcheng Fu^{1

2

3}, Song Jin^{1

2

3}

Affiliations

¹ National Clinical Research Centre for Haematologic Diseases, Jiangsu Institute of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
² Institute of Blood and Marrow Transplantation, Collaborative Innovation Centre of Haematology, Soochow University, Suzhou, China.
³ Key Laboratory of Thrombosis and Haemostasis of Ministry of Health, Suzhou, China.

PMID: 38557299
DOI: 10.1080/10428194.2024.2329322

No abstract available